This article is more than 5 years old. Information may no longer be current.
Nuvesse announces positive topline data for Cellulation serum use after aesthetic skin treatments
Click Here to Manage Email Alerts
SAN FRANCISCO - Nuvesse Skin Therapies has announced positive results for its Cellulation Technology from four different treatment protocols at the American Academy of Dermatology Annual Meeting.
The serum technology was shown to actively deliver topically applied skin therapies into the epidermis to calm, cool and hydrate the skin following aesthetic medical skin treatments, according to a company press release.
Derived from a wound care application to deliver large molecules across the outer skin barrier to penetrate the epidermis, Cellulation can be applied as a topical mask or through a roller application, the release stated.
In the first clinical protocol, which evaluated the safety and efficacy of Nuvesse Serum No. 3 Post Treatment mask as a therapy following ablative or fractional ablative laser resurfacing, all of the investigators involved agreed that patient healing time was shortened vs. standard post-treatment protocol. All patients were satisfied with using the mask, and 91% of physicians would use the product again, according to the press release.
Within the other three protocols, Nuvesse Serum No. 5 Hydrating mask was evaluated as an adjunctive agent in microdermabrasion, and Serum No. 25 Lip and Serum No. 21 Crow's Feet Mask were evaluated as adjuvant agents for cosmetic facial procedures.
During the microdermabrasion protocol, erythema was found to be resolved more quickly according to 91% of the investigators, and 97% of the investigators said they would use the product again, according to the release.
Following cosmetic facial procedures, 60% of investigators agreed or strongly agreed that fine lines and wrinkles appeared to improve after one treatment, and 94% said they would use the product again.
Complete data from the trials, which involved a total of 140 patients, have been accepted for upcoming publication in a peer-reviewed medical journal, the release stated.
Reference: www.nuvessemd.com.